Kilitch Drugs (India) informs about closure of trading windows
Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time read with Code of Prohibition of Insider Trading of the Company, Kilitch Drugs (India) has informed that the Trading Windows for dealing in Securities of the Company will remain closed for all the Designated Persons of the Company and their immediate relatives with effect from Wednesday, 1st April, 2026 till the expiry of 48 hours after the declaration of Financial Results of the Company for the quarter and year ended 31st March, 2026. The date of meeting of Board of Directors to approve the audited financial results of the Company for the quarter and year ended 31st March, 2026 shall be intimated in due course
The above information is a part of company’s filings submitted to BSE.
